JASON FLEURY: Open Payments
NPI 1386885069 · CANTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$769 in 36 payments from 14 companies in 2025. Trend: 2023 $844 · 2024 $672 · 2025 $769
Food & beverage: $749Education: $20
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $137 |
| Merck Sharp & Dohme LLC | 4 | $88 |
| E.R. Squibb & Sons, L.L.C. | 5 | $86 |
| Boston Scientific Corporation | 2 | $71 |
| PFIZER INC. | 3 | $69 |
| Amgen Inc. | 3 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $60 |
| Esperion Therapeutics, Inc. | 3 | $53 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $43 |
| Inspire Medical Systems, Inc. | 1 | $29 |
Products named: LEQVIO, VERQUVO, ELIQUIS, REPATHA, Kerendia, NEXLETOL, VYNDAQEL, LifeVest.
Industry payments across GA — which companies pay providers there.
